Magnesium in PDB 8qc7: New Monoclinic Ecispe

All present enzymatic activity of New Monoclinic Ecispe:
2.7.1.148;

The structure of New Monoclinic Ecispe, PDB code: 8qc7 was solved by R.Hamid, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	35.39 / 2.03
Space group	C 1 2 1
Cell size a, b, c (Å), α, β, γ (°)	143.196, 53.046, 91.07, 90, 126.93, 90
R / Rfree (%)	21.6 / 24

The binding sites of Magnesium atom in the New Monoclinic Ecispe (pdb code 8qc7). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the New Monoclinic Ecispe, PDB code: 8qc7:
Jump to Magnesium binding site number: 1; 2;

Magnesium binding site 1 out of 2 in the New Monoclinic Ecispe


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of New Monoclinic Ecispe within 5.0Å range: probe atom residue distance (Å) B Occ A:Mg303 b:38.2 occ:1.00 O2B A:CDM301 1.9 36.0 1.0 O A:HOH435 2.3 27.0 1.0 O1B A:ADP302 2.3 28.4 1.0 O1A A:ADP302 3.1 28.4 1.0 PB A:CDM301 3.3 30.6 1.0 PB A:ADP302 3.5 30.0 1.0 O3A A:ADP302 3.6 28.9 1.0 O A:HOH461 3.6 26.5 1.0 H1M2 A:CDM301 3.8 37.6 1.0 OG A:SER108 3.8 30.9 1.0 O3A A:CDM301 3.9 34.1 1.0 PA A:ADP302 3.9 35.7 1.0 O1B A:CDM301 3.9 29.9 1.0 O A:HOH444 4.1 27.9 1.0 O3B A:ADP302 4.2 31.7 1.0 O5' A:ADP302 4.3 31.8 1.0 OD2 A:ASP141 4.4 30.4 1.0 O3B A:CDM301 4.5 34.8 1.0 OG1 A:THR181 4.5 31.8 1.0 C1M A:CDM301 4.6 31.3 1.0 O2B A:ADP302 4.7 31.6 1.0 H3M A:CDM301 4.7 35.5 1.0 CA A:GLY105 4.7 26.3 1.0 O3M A:CDM301 4.8 29.6 1.0

Magnesium binding site 2 out of 2 in the New Monoclinic Ecispe


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 2 of New Monoclinic Ecispe within 5.0Å range: probe atom residue distance (Å) B Occ B:Mg303 b:45.0 occ:1.00 O1A B:ADP302 2.1 44.1 1.0 OG B:SER108 2.5 34.8 1.0 O B:HOH409 2.5 36.1 1.0 O B:HOH407 2.7 37.8 1.0 O1B B:ADP302 3.0 52.4 1.0 N B:SER108 3.2 29.4 1.0 O1B B:CDM301 3.4 40.1 1.0 PA B:ADP302 3.4 63.2 1.0 CB B:SER108 3.5 30.2 1.0 O5' B:ADP302 3.7 51.4 1.0 CA B:SER108 3.9 27.6 1.0 PB B:ADP302 4.0 49.9 1.0 C B:GLY107 4.1 30.1 1.0 CA B:GLY105 4.2 33.4 1.0 O3A B:ADP302 4.2 47.5 1.0 O2B B:CDM301 4.2 34.9 1.0 N B:GLY107 4.2 30.4 1.0 O2B B:ADP302 4.2 45.7 1.0 CA B:GLY107 4.3 31.4 1.0 C B:GLY105 4.3 31.9 1.0 PB B:CDM301 4.4 36.7 1.0 O B:GLY105 4.5 31.4 1.0 O2A B:ADP302 4.6 46.0 1.0 CD1 B:LEU66 4.6 33.0 1.0 N B:GLY106 4.8 26.3 1.0 OD2 B:ASP141 4.9 33.5 1.0 CB B:ASP141 5.0 29.7 1.0

R.Hamid, R.Hamid. N/A N/A.